Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Engelhardt

Showing results (231-240 of 255) with videos related to

Pageof 26
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2017
Cytomegalovirus (CMV) Epitope-Specific CD4<sup>+</sup> T Cells Are Inflated in HIV<sup>+</sup> CMV<sup>+</sup> SubjectsChike O Abana, Mark A Pilkinton, Silvana Gaudieri, et al.
Vaccine|August 25, 2012
WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011Alexander I Klimov, Rebecca Garten, Colin Russell, et al.
The Oncologist|July 1, 2018
Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled TrialInge Henselmans, Hanneke W M van Laarhoven, Hanneke C J M de Haes, et al.
Frontiers in Immunology|June 9, 2025
Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortiumVictor M Cnossen, Paula C Leao Moreira, Othmar G Engelhardt, et al.
Patient Education and Counseling|March 29, 2025
Implementation of a patient decision aid for discharge planning of hospitalized patients with stroke: aprocess evaluation using a mixed-methods approachJ C M Prick, E G Engelhardt, F K Lansink Rotgerink, et al.
Vaccine|March 4, 2014
WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013Ian G Barr, Colin Russell, Terry G Besselaar, et al.
Frontiers in Immunology|May 5, 2023
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative studyJoanna Waldock, Edmond J Remarque, Lingyi Zheng, et al.
Frontiers in Immunology|July 5, 2022
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative StudyMarie-Clotilde Bernard, Joanna Waldock, Sylvie Commandeur, et al.
Familial Cancer|February 22, 2015
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON studyM R Wevers, M K Schmidt, E G Engelhardt, et al.
BMC Medical Informatics and Decision Making|September 30, 2025
Evaluating the effectiveness of a risk prediction model (PERSARC) on improving treatment decisions quality for patients with soft-tissue sarcomas: the VALUE-PERSARC studyAnouk A Kruiswijk, Perla J Marang-van de Mheen, Lisa A E Vlug, et al.
Pageof 26

Showing results (231-240 of 255) with videos related to

Sort By:
Pageof 26
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2017
Cytomegalovirus (CMV) Epitope-Specific CD4<sup>+</sup> T Cells Are Inflated in HIV<sup>+</sup> CMV<sup>+</sup> SubjectsChike O Abana, Mark A Pilkinton, Silvana Gaudieri, et al.
Vaccine|August 25, 2012
WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011Alexander I Klimov, Rebecca Garten, Colin Russell, et al.
The Oncologist|July 1, 2018
Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled TrialInge Henselmans, Hanneke W M van Laarhoven, Hanneke C J M de Haes, et al.
Frontiers in Immunology|June 9, 2025
Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortiumVictor M Cnossen, Paula C Leao Moreira, Othmar G Engelhardt, et al.
Patient Education and Counseling|March 29, 2025
Implementation of a patient decision aid for discharge planning of hospitalized patients with stroke: aprocess evaluation using a mixed-methods approachJ C M Prick, E G Engelhardt, F K Lansink Rotgerink, et al.
Vaccine|March 4, 2014
WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013Ian G Barr, Colin Russell, Terry G Besselaar, et al.
Frontiers in Immunology|May 5, 2023
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative studyJoanna Waldock, Edmond J Remarque, Lingyi Zheng, et al.
Frontiers in Immunology|July 5, 2022
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative StudyMarie-Clotilde Bernard, Joanna Waldock, Sylvie Commandeur, et al.
Familial Cancer|February 22, 2015
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON studyM R Wevers, M K Schmidt, E G Engelhardt, et al.
BMC Medical Informatics and Decision Making|September 30, 2025
Evaluating the effectiveness of a risk prediction model (PERSARC) on improving treatment decisions quality for patients with soft-tissue sarcomas: the VALUE-PERSARC studyAnouk A Kruiswijk, Perla J Marang-van de Mheen, Lisa A E Vlug, et al.
Pageof 26